22
total announcements
544293.BO · 15 min delayed
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd has announced the voting results and scrutinizer's report for its 21st Annual General Meeting (AGM) held on September 22, 2026. The meeting was conducted through video conferencing and all resolutions were passed with 100% approval from shareholders.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd has held its 21st Annual General Meeting (AGM) through video conferencing, where all resolutions were passed by the requisite majority. The company declared a final dividend of ₹ 0.50 per equity share and appointed a new director. The meeting was conducted in accordance with SEBI and MCA guidelines.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd held its 21st Annual General Meeting (AGM) on September 22, 2026, where all resolutions were passed by the requisite majority. The company declared a final dividend of ₹ 0.50 per equity share and appointed a new director. The meeting was conducted through video conferencing and the proceedings will be available on the company's website.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd has published a newspaper advertisement regarding the Notice of the 21st Annual General Meeting and e-voting information. The meeting is scheduled to be held on September 22, 2026, through video conferencing. The advertisement is published in Business Standard (English) and Aajkaal (Bengali).
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd has announced the 21st Annual General Meeting (AGM) to be held on September 22, 2026, through Video Conference (VC) / Other Audio Visual Means (OAVM). The company has also made available the Annual Report for the Financial Year 2025-26 on its website and on the websites of the stock exchanges where its securities are listed.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd has announced the Notice of 21st Annual General Meeting (AGM) scheduled to be held on 22nd September, 2026. The AGM notice is available on the company's website and has been dispatched to members through electronic mode.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd has released its Annual Report for FY 2025-26, including a notice for the 21st Annual General Meeting (AGM) scheduled on 22nd September 2026. The report is available on the company's website and has been sent to members via email.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd has published a newspaper advertisement for the 21st Annual General Meeting (AGM) of the Company for FY 2025-26, scheduled to be held on 22 September, 2026.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd has published a newspaper advertisement for its 21st Annual General Meeting (AGM) to be held on 22 September, 2026. The meeting will be held through video conferencing/audio-visual means. The intimation is also available on the company's website.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd reported a strong start to FY '27 with 21% revenue growth, 28% EBITDA growth, and 40% PAT growth in Q1 FY '27. The company highlighted its focus on building clinical capabilities, staying ahead in technology, and improving patient experience.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd has announced the availability of the audio recording of their earnings call held on 13 August 2026, in relation to their unaudited financial results for the quarter ended 30 June 2026. The recording is available on their website.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd has announced the availability of the audio recording of its earnings call held on 13 August 2026, discussing unaudited financial results for Q4 and FY26-27.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd published unaudited financial results for the quarter ended 30 June 2026, showing a total income of Rs. 441.96 crore, EBITDA of Rs. 58.93 crore, and a profit after tax of Rs. 18.62 crore. The company also announced changes in the fund management responsibilities for Sundaram Mutual Fund's schemes.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd has announced its Q1 FY27 results, with revenue from operations at INR 876.5 Mn, a 21% YoY growth, and EBITDA margin of 36.0%. The company has expanded its network with new centres in West Bengal and Jharkhand, and its Suraksha Genomics business has grown 136% YoY.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Limited announced its unaudited financial results for the quarter ended 30 June 2026, with PAT growing by 40% year-on-year and EBITDA increasing by 28% year-on-year. The company's revenue grew 21% YoY in Q1 FY27, with EBITDA margin improving to 36.0%. Suraksha Genomics continued its strong growth trajectory, delivering revenue growth of 136% YoY in Q1 FY27.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd has fixed a revised record date of 15 September 2026 for determining shareholder entitlement to receive dividend for the financial year ended 31 March 2026.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd has announced the appointment of Mr. Dinesh Gupta as the Chief Financial Officer (CFO) of the company, effective from 24 August 2026. The company has also approved the unaudited financial results for the quarter ended 30 June 2026 and fixed 15 September 2026 as the record date for the purpose of determining the entitlement of shareholders to receive dividend for the financial year ended 31 March 2026.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd has approved unaudited financial results for the quarter ended 30 June 2026, with the results being made available on the company's website. The board also approved the appointment of Mr. Dinesh Gupta as the Chief Financial Officer, and fixed the record date for the purpose of determining the entitlement of shareholders to receive dividend for the financial year ended 31 March 2026.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd announced its unaudited financial results for the quarter ended 30 June, 2026, and the appointment of Mr. Dinesh Gupta as the Chief Financial Officer. The company also fixed the record date for the purpose of determining the entitlement of shareholders to receive dividend for the financial year ended 31 March 2026.
Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd has postponed its 21st Annual General Meeting (AGM) scheduled for September 2, 2026, due to unavoidable circumstances. The revised date, time, and venue will be announced later, in accordance with applicable laws and regulations.